Clinical Trial Update: Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 3]

View source ↗

Summary

A Phase 3 trial assessed the immunogenicity and safety of a combined measles, mumps, rubella and varicella vaccine (MMRV) developed by GlaxoSmithKline; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• Priorix-Tetra (Measles, Mumps, Rubella, Varicella vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Mumps, Varicella | Phase 3 | Status: COMPLETED